AB Science Statistics
Total Valuation
AB Science has a market cap or net worth of EUR 71.18 million. The enterprise value is 85.23 million.
| Market Cap | 71.18M |
| Enterprise Value | 85.23M |
Important Dates
The last earnings date was Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AB Science has 76.54 million shares outstanding. The number of shares has decreased by -2.58% in one year.
| Current Share Class | 69.78M |
| Shares Outstanding | 76.54M |
| Shares Change (YoY) | -2.58% |
| Shares Change (QoQ) | -22.05% |
| Owned by Insiders (%) | 25.80% |
| Owned by Institutions (%) | 0.00% |
| Float | 35.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 60.63 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -54.74 |
| EV / Sales | 72.60 |
| EV / EBITDA | 82.51 |
| EV / EBIT | 133.38 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0.19 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 10.76% |
| Revenue Per Employee | 32,611 |
| Profits Per Employee | -43,250 |
| Employee Count | 36 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.20% in the last 52 weeks. The beta is 1.18, so AB Science's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -19.20% |
| 50-Day Moving Average | 1.08 |
| 200-Day Moving Average | 1.23 |
| Relative Strength Index (RSI) | 35.60 |
| Average Volume (20 Days) | 305,688 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AB Science had revenue of EUR 1.17 million and -1.56 million in losses. Loss per share was -0.03.
| Revenue | 1.17M |
| Gross Profit | 978,000 |
| Operating Income | 639,000 |
| Pretax Income | -1.56M |
| Net Income | -1.56M |
| EBITDA | 1.03M |
| EBIT | 639,000 |
| Loss Per Share | -0.03 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 394,000 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 83.30%, with operating and profit margins of 54.43% and -132.62%.
| Gross Margin | 83.30% |
| Operating Margin | 54.43% |
| Pretax Margin | -132.62% |
| Profit Margin | -132.62% |
| EBITDA Margin | 87.99% |
| EBIT Margin | 54.43% |
| FCF Margin | n/a |
Dividends & Yields
AB Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.58% |
| Shareholder Yield | 2.58% |
| Earnings Yield | -2.19% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |